Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
HALOZYME THERAPEUTICS, INC. | Director | Common Stock | 69.9K | $4.03M | $57.70 | Aug 14, 2024 | Direct |
DermTech, Inc. | Director | Common Stock | 158K | $237K | $1.50 | Jun 1, 2023 | Direct |
HALOZYME THERAPEUTICS, INC. | Director | Option to Purchase Common Stock | 8.8K | $122K | $13.87 | Apr 25, 2024 | Direct |
Talis Biomedical Corp | Director | Stock option (right to buy) | 95K | Jun 9, 2023 | Direct | ||
Nautilus Biotechnology, Inc. | Director | Stock Option (Right to Buy) | 45K | Jun 14, 2024 | Direct |